Cargando…
Pharmacokinetics of neutron-irradiated meglumine antimoniate in Leishmania amazonensis-infected BALB/c mice
BACKGROUND: Cutaneous leishmaniasis (CL) is a parasitic disease caused by the protozoan Leishmania spp. Pentavalent antimonial agents have been used as an effective therapy, despite their side effects and resistant cases. Their pharmacokinetics remain largely unexplored. This study aimed to investig...
Autores principales: | Borborema, Samanta Etel Treiger, Osso, João Alberto, de Andrade, Heitor Franco, do Nascimento, Nanci |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Estudos de Venenos e Animais Peçonhentos - CEVAP,
Universidade Estadual Paulista - UNESP
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521709/ https://www.ncbi.nlm.nih.gov/pubmed/31130998 http://dx.doi.org/10.1590/1678-9199-JVATITD-1446-18 |
Ejemplares similares
-
Biodistribution of meglumine antimoniate in healthy and
Leishmania (Leishmania) infantum chagasi-infected BALB/c
mice
por: Borborema, Samanta Etel Treiger, et al.
Publicado: (2013) -
AgNP-PVP-meglumine antimoniate nanocomposite reduces Leishmania amazonensis infection in macrophages
por: Gélvez, Ana Patricia Cacua, et al.
Publicado: (2021) -
Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia)
por: Gómez, María Adelaida, et al.
Publicado: (2020) -
The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis
por: Gonçalves-Oliveira, Luiz Filipe, et al.
Publicado: (2019) -
Effect of hydroalcoholic extract of Echinacea purpurea in combination with meglumine antimoniate on treatment of Leishmania major-induced cutaneous leishmaniasis in BALB/c mice
por: Sarkari, Bahador, et al.
Publicado: (2017)